共 18 条
[1]
APRILE MA, 1966, C J PUBLIC HEALTH, V57, P343
[2]
Cameron J, 1976, Adv Appl Microbiol, V20, P57, DOI 10.1016/S0065-2164(08)70109-6
[3]
CAMERON J, 1979, 1978 INT S PERT NAT, P200
[4]
CAMERON J, 1972, P S COMBINED VACCINE, P55
[5]
EFFECTS OF ELEVATED-TEMPERATURES ON THE OPACITY AND TOXICITY OF PERTUSSIS VACCINES MANUFACTURED WITH DIFFERENT INACTIVATING AGENTS
[J].
VACCINE,
1986, 4 (03)
:185-190
GUPTA, RK
;
SHARMA, SB
;
AHUJA, S
;
SAXENA, SN
.
[6]
GUPTA RK, 1986, J BIOL STAND, V15, P87
[7]
KENDRICK PL, 1947, AM J PUBLIC HEALTH, V37, P803
[8]
Manclark CR, 1984, BACTERIAL VACCINES, P69
[9]
MILLER JJ, 1949, PEDIATRICS, V4, P468
[10]
USE OF BORDETELLA-PERTUSSIS PRESERVED IN LIQUID-NITROGEN AS A CHALLENGE SUSPENSION IN KENDRICK MOUSE PROTECTION TEST
[J].
JOURNAL OF BIOLOGICAL STANDARDIZATION,
1975, 3 (01)
:11-29
NOVOTNY, P
;
BROOKES, JE
.